1. Home
  2. ENOV vs LMAT Comparison

ENOV vs LMAT Comparison

Compare ENOV & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • LMAT
  • Stock Information
  • Founded
  • ENOV 1995
  • LMAT 1983
  • Country
  • ENOV United States
  • LMAT United States
  • Employees
  • ENOV N/A
  • LMAT N/A
  • Industry
  • ENOV Fluid Controls
  • LMAT Medical/Dental Instruments
  • Sector
  • ENOV Industrials
  • LMAT Health Care
  • Exchange
  • ENOV Nasdaq
  • LMAT Nasdaq
  • Market Cap
  • ENOV 1.7B
  • LMAT 1.9B
  • IPO Year
  • ENOV 2008
  • LMAT 2006
  • Fundamental
  • Price
  • ENOV $26.48
  • LMAT $79.77
  • Analyst Decision
  • ENOV Strong Buy
  • LMAT Buy
  • Analyst Count
  • ENOV 5
  • LMAT 6
  • Target Price
  • ENOV $55.60
  • LMAT $100.80
  • AVG Volume (30 Days)
  • ENOV 1.7M
  • LMAT 137.2K
  • Earning Date
  • ENOV 08-07-2025
  • LMAT 08-05-2025
  • Dividend Yield
  • ENOV N/A
  • LMAT 0.97%
  • EPS Growth
  • ENOV N/A
  • LMAT 30.45
  • EPS
  • ENOV N/A
  • LMAT 1.97
  • Revenue
  • ENOV $2,150,191,000.00
  • LMAT $226,256,000.00
  • Revenue This Year
  • ENOV $8.23
  • LMAT $13.88
  • Revenue Next Year
  • ENOV $6.18
  • LMAT $8.81
  • P/E Ratio
  • ENOV N/A
  • LMAT $41.69
  • Revenue Growth
  • ENOV 18.32
  • LMAT 13.19
  • 52 Week Low
  • ENOV $26.31
  • LMAT $71.42
  • 52 Week High
  • ENOV $49.83
  • LMAT $109.58
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 42.48
  • LMAT 38.27
  • Support Level
  • ENOV $29.74
  • LMAT $82.77
  • Resistance Level
  • ENOV $36.82
  • LMAT $86.94
  • Average True Range (ATR)
  • ENOV 1.39
  • LMAT 2.09
  • MACD
  • ENOV -0.30
  • LMAT -0.36
  • Stochastic Oscillator
  • ENOV 16.77
  • LMAT 1.65

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Share on Social Networks: